4//SEC Filing
INVIVO THERAPEUTICS HOLDINGS CORP. 4
Accession 0001179110-14-005864
CIK 0001292519operating
Filed
Mar 25, 8:00 PM ET
Accepted
Mar 26, 5:41 PM ET
Size
5.5 KB
Accession
0001179110-14-005864
Insider Transaction Report
Form 4
Ulich Thomas R
Chief Scientific Officer
Transactions
- Award
STOCK OPTION (RIGHT TO BUY)
2014-02-24+350,000→ 350,000 totalExercise: $2.33Exp: 2024-02-23→ COMMON STOCK (350,000 underlying)
Footnotes (1)
- [F1]The option is exercisable as to 25% of the shares on the first anniversary of the date of grant, and the remaining shares vest thereafter on a monthly basis in 36 equal monthly installments.
Documents
Issuer
INVIVO THERAPEUTICS HOLDINGS CORP.
CIK 0001292519
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001292519
Filing Metadata
- Form type
- 4
- Filed
- Mar 25, 8:00 PM ET
- Accepted
- Mar 26, 5:41 PM ET
- Size
- 5.5 KB